[1]
Meier, C.R. 2006. Pharmacoepidemiology – Assessing the Risks and Benefits of Drugs in the Postmarketing Phase. CHIMIA. 60, 1-2 (Feb. 2006), 54. DOI:https://doi.org/10.2533/000942906777675272.